-- 週二早盤，美元兌主要貿易夥伴走強，此前費城聯邦儲備銀行將於美東時間上午8:30公佈4月份非製造業報告和3月份零售銷售數據。 每週的《紅皮書》同店銷售數據將於美東時間上午8:55公佈，隨後是3月份的成屋銷售數據和2月份的商業庫存數據，這兩項數據均將於美東時間上午10:00公佈，同時還將舉行美聯儲主席凱文·沃什的提名聽證會。 聯準會理事克里斯多福沃勒將於美東時間下午2:30發表講話，但由於4月28日至29日聯邦公開市場委員會會議前的靜默期，他不太可能就經濟或貨幣政策發表任何評論。 以下是周二外匯市場活動的簡要概述： 歐元兌美元從週一美股收盤時的1.1786和周一早盤同一時間的1.1771跌至1.1763。根據隔夜公佈的數據，歐元區4月經濟景氣指數下降。歐洲央行下次會議定於4月30日舉行。 英鎊兌美元匯率從週一美國收盤時的1.3533和周一早盤同一時間的1.3520跌至1.3510。英國2月就業及收入成長放緩，失業率在當月有所下降，但3月英國首次申請失業救濟人數增加。英國央行下次會議定於4月30日舉行。 美元/日圓匯率從週一美國收盤時的158.8456和週一早盤同一時間的158.9285上升至159.2261。隔夜沒有公佈日本經濟數據。日本央行下次會議定於4月27日至28日舉行。 美元/加幣匯率從週一美國收盤時的1.3646升至1.3657，但週一早盤同一時間仍低於1.3686的水平。週二的日程安排中沒有加拿大經濟數據公佈。加拿大央行下次會議定於4月29日舉行。
Related Articles
Research
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
$HIG
Research
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
$BKR
Research
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.
$WAB